# Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair

> clinical trial · VERIFIED · 2026-07-30

Status: ACTIVE_NOT_RECRUITING · Sponsor: National Cancer Institute (NCI) · Condition: Colon Adenocarcinoma

- Company: National Cancer Institute (NCI)
- Sector: Colon Adenocarcinoma
- Primary source: https://clinicaltrials.gov/study/NCT02912559

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.